Literature DB >> 21488470

The validation of the EQ-5D in Malaysian dialysis patients.

A Faridah1, H Jamaiyah, A Goh, A Soraya.   

Abstract

The EQ-5D is a quality of life instrument that measures five dimensions of health. This study investigated the reliability and validity of its use in the Malaysian dialysis population. Test-retest reliability, convergent and discriminant validity were assessed. Responses of 86 subjects who completed both surveys were used in analysis. Test-retest reliability using Cohen's kappa was acceptable in four out of five dimensions, with the exception of self-care. Convergent validity was present. Discriminant validity was found in only two out of six hypotheses tested. In conclusion, the EQ-5D has potential in this population but further study is required.

Entities:  

Mesh:

Year:  2010        PMID: 21488470

Source DB:  PubMed          Journal:  Med J Malaysia        ISSN: 0300-5283


  4 in total

1.  Psychometric performance assessment of Malay and Malaysian English version of EQ-5D-5L in the Malaysian population.

Authors:  Asrul Akmal Shafie; Annushiah Vasan Thakumar; Ching Jou Lim; Nan Luo
Journal:  Qual Life Res       Date:  2018-10-13       Impact factor: 4.147

2.  The validity of the EQ-5D-3L items: an investigation with type 2 diabetes patients from six European countries.

Authors:  Uwe Konerding; Sylvia G Elkhuizen; Raquel Faubel; Paul Forte; Tomi Malmström; Elpida Pavi; M F Bas Janssen
Journal:  Health Qual Life Outcomes       Date:  2014-12-05       Impact factor: 3.186

Review 3.  Measurement Properties of Commonly Used Generic Preference-Based Measures in East and South-East Asia: A Systematic Review.

Authors:  Xinyu Qian; Rachel Lee-Yin Tan; Ling-Hsiang Chuang; Nan Luo
Journal:  Pharmacoeconomics       Date:  2020-02       Impact factor: 4.981

4.  Factors affecting quality of life in patients on haemodialysis: a cross-sectional study from Palestine.

Authors:  Sa'ed H Zyoud; Dala N Daraghmeh; Diana O Mezyed; Razan L Khdeir; Mayas N Sawafta; Nora A Ayaseh; Ghada H Tabeeb; Waleed M Sweileh; Rahmat Awang; Samah W Al-Jabi
Journal:  BMC Nephrol       Date:  2016-04-27       Impact factor: 2.388

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.